After completing this activity, participants should be better able to: Assess the pathophysiology, epidemiology, and disease burden of EoE, including its health and economic costs, to inform managed care decisions Apply current evidence-based guidelines for the diagnosis and management of EoE to the development of managed care utilization pathways Incorporate evidence on the value of current and emerging therapies into coverage and benefit design considerations, including their impact on patients and caregivers
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 35 Nutmeg Drive
Pricing
100% of listed courses are free
20 of 20 courses listed here are free.
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
Available fromDec 15, 2026
-
Last day to claim creditDec 16, 2027 1 year left
-
Medscape, LLC Identifying Suboptimally Managed Erosive Esophagitis in Clinical Practice
-
Clinical Care Options, LLC (dba Decera Clinical Education) Aligned With Evidence: Managed Care Strategies to Optimize Vaccine Uptake
-
Impact Education +1 Continuous Glucose Monitoring in Managed Care: Emerging Evidence, Quality Trends, and Policy Implications
-
Talem Health, LLC Optimizing Managed Care Decision-Making in Advanced Nonmelanoma Skin Cancer: Integrating Evidence, Guidelines, and Care Pathways
-
Talem Health, LLC Integrating Immunotherapy Into Guideline-Based Care: Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma
-
Talem Health, LLC Optimizing Frontline Treatment Decisions in CLL: Evolving Evidence and Real-World Applications
